Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1992
Patterns of antibody specificity during the BALB/c immune response to hen eggwhite lysozymeM A Newman, C R Mainhart, C P Mallett, et al.
Acta Psychiatrica Scandinavica|April 1, 1995
Cognitive function, thyroid status and postpartum depressionP Mallett, M Andrew, C Hunter, et al.
Infection and Immunity|July 16, 2002
Tissue tropism of enteropathogenic Escherichia coli strains belonging to the O55 serogroupR J Fitzhenry, S Reece, L R Trabulsi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 1998
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challengeG M Glenn, T Scharton-Kersten, R Vassell, et al.
Infection and Immunity|June 13, 2001
Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adultsL F Fries, A D Montemarano, C P Mallett, et al.
Infection and Immunity|May 1, 1995
Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infectionL L van de Verg, C P Mallett, H H Collins, et al.
Infection and Immunity|June 1, 1995
Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infectionC P Mallett, T L Hale, R W Kaminski, et al.
Molecular Immunology|April 1, 1989
Organ reactive autoantibodies from non-immunized adult BALB/c mice are polyreactive and express non-biased VH gene usageA B Hartman, C P Mallett, J Srinivasappa, et al.
Regulatory Toxicology and Pharmacology : RTP|March 3, 2020
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbitsÉric Destexhe, Émilie Grosdidier, Adèle Bouhraoua, et al.
NPJ Vaccines|July 10, 2025
Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvantsKirill Vasilev, Irene Hoxie, Eduard Puente-Massaguer, et al.
Pageof 8